Arcus Biosciences, Inc. (RCUS)

23.09 -0.03 (-0.13%) USD  |  NYSE  |  Dec 26, 16:00
23.11 +0.02 (+0.09%) After-Hours: 20:00
More

Arcus Biosciences Amortization Expense CF (% of Quarterly Assets)

Amortization Expense CF (% of Quarterly Assets) Chart

View Amortization Expense CF (% of Quarterly Assets) for RCUS.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Amortization Expense CF (% of Quarterly Assets) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Amortization Expense CF (% of Quarterly Assets) Range, Past 5 Years

View Amortization Expense CF (% of Quarterly Assets) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Amortization Expense CF (% of Quarterly Assets) Benchmarks

View Amortization Expense CF (% of Quarterly Assets) Benchmarks
Start Trial
Gilead Sciences, Inc. Upgrade
Actinium Pharmaceuticals, Inc. --
Madrigal Pharmaceuticals, Inc. --
Karyopharm Therapeutics, Inc. --
Janux Therapeutics, Inc. --